Carisma Therapeutics to Participate in the Jefferies Global Healthcare ConferencePRNewsWire • Thursday
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-MonocytePRNewsWire • 05/16/24
Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/09/24
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsPRNewsWire • 05/09/24
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024PRNewsWire • 05/08/24
Carisma Therapeutics to Participate in The Citizens JMP Life Sciences ConferencePRNewsWire • 05/06/24
Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 05/02/24
Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingPRNewsWire • 04/22/24
Here's Why CARISMA THERAP (CARM) Is a Great 'Buy the Bottom' Stock NowZacks Investment Research • 04/04/24
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsPRNewsWire • 04/01/24
Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual MeetingPRNewsWire • 03/21/24
Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care ConferencePRNewsWire • 02/28/24
Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferencePRNewsWire • 12/21/23
First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna CollaborationPRNewsWire • 12/14/23
Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-MonocytePRNewsWire • 11/28/23
Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business HighlightsPRNewsWire • 11/09/23
Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITCPRNewsWire • 10/31/23
Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023PRNewsWire • 10/25/23
Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR SummitPRNewsWire • 09/01/23